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Abstract
Background: Free radical mediated oxidative stress is mainly involved in the pathogenesis of
diabetic complications. Proteins and lipids are among the prime targets for oxidative stress. In the
present study, we evaluated the oxidative stress in chronic IDDM patients by estimating the lipid
peroxidation, protein oxidation, and antioxidants status.
Subjects and design: A total of 35 (15 IDDM + 20 normal healthy) children were examined in
the study and estimated the lipid peroxidation, protein oxidation, and antioxidants – vitamin A (β-
carotene, retinol), vitamin C, vitamin E and enzymatic antioxidants and nitric oxide.
Results: A statistically significant higher values of protein carbonyl groups and MDA as lipid
peroxides were observed in diabetic patients with slight reduction in the synthesis of nitric oxide.
It is interesting to note that there was a decrease in the antioxidant levels with corresponding
increased protein and lipid oxidation. On PAGE under native conditions, we observed decreased
levels of proteins – albumin, transferrin, ceruloplasmin and heptoglobulins and variable GC globulin
fractions in IDDM compared to normal healthy controls.
Conclusion: Hyperglycemia induces the overproduction of oxygen free radicals and consequently
increases the protein oxidation and lipid oxidation. A significance difference in the mean plasma
concentration of total antioxidant status was observed in IDDM patients. The findings of the
present study suggest that diabetes in an altered metabolic state of oxidation-reduction and that it
is convenient to give therapeutic interventions with antioxidants.
Background
Free radicals are very reactive chemical species, can cause
oxidation injury to the living beings by attacking the mac-
romolecules like lipids, carbohydrates, proteins and
nucleic acids. Under normal physiological conditions,
there is a critical balance in the generation of oxygen free
radicals and antioxidant defense systems used by organ-
isms to deactivate and protect themselves against free rad-
ical toxicity [1,2]. Impairment in the oxidant/antioxidant
equilibrium creates a condition known as oxidative stress.
Oxidative stress is known to be a component of molecular
and cellular tissue damage mechanisms in a wide spec-
trum of human diseases [3-5].
Diabetes is associated with a number of metabolic altera-
tions and principal among these is hyperglycemia. The
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precise mechanism by which hyperglycemia may contrib-
ute to the development of coronary heart disease (CHD)
is a matter of some controversy. Known sequelae of hyper-
glycemia such as cellular damage, increased extra cellular
matrix production and vascular dysfunction have all been
implicated in the pathogenesis of vascular disease in type
I and type II diabetes [3,5-10]. Mechanisms involved in
the increased oxidative stress in diabetes include not only
oxygen free radical generation due to nonenzymatic glyc-
osylation (glycation), autooxidation of glycation prod-
ucts, but also changes in the tissue content and activity of
antioxidant defense systems. Increased levels of the prod-
ucts of oxidative damage to lipids have been detected in
serum of diabetic patients, and their presence correlates
with the development of complications [6,10-15]. A vari-
ety of natural antioxidants exist to scavenge oxygen free
radicals and prevent oxidative damage to biological mem-
branes. One group of these antioxidants is enzymatic
(intracellular), which include super oxide dismutase, glu-
tathione peroxidase and catalase. In addition to enzy-
matic antioxidants, the major natural antioxidants, most
of them derived from natural sources by dietary intake are
vitamin A, vitamin C and vitamin E and carotenoids. Also,
numerous small molecules are synthesized or produced
within the body that has antioxidant capacity (e.g. glu-
tathione and uric acid) [3,6,14-18].
There are several studies evaluated the free radical induced
lipid peroxidation and the antioxidants in diabetic
patients. Many of these studies assessed individual anti-
oxidants that act cooperatively in vivo to provide greater
protection to the organism against free radical damage
than could be provided by any single antioxidant acting
alone. Controversial reports have been reported concern-
ing the antioxidant status in diabetic patients [17,19-21].
Protein oxidation, in contrast to lipid peroxidation, does
not have the features of chain reactions. The plasma pro-
teins destructed by peroxidation have a quite long period.
Therefore, the evaluation of protein oxidation (PCG) in
plasma is a respected marker of free radical intensity.
There are only a few reports regarding the protein oxida-
tion in various other pathogenic conditions and no
reports are available for that processes along with antioxi-
dants in type I diabetic patients. The aim of the present
study was to evaluate the free radical reaction intensity in
chronic diabetic IDDM patients on basis of protein carbo-
nyl groups of proteins, lipid peroxidation and the status of
antioxidants in plasma.
Subjects and methods
Subjects
A total of 35 (15 IDDM + 20 normal healthy) children
were examined in the study. Based on preliminary survey,
all 15 patients are treated but controlled who had the high
levels of blood glucose and glycosylated hemoglobin
(Gly-Hb), well above the normal ranges, were selected for
the study. These children were treated with insulin, had
no other medications and they had no supplemental
intake of vitamins or other nutrients. The remaining 20
age-matched healthy children were chosen from the com-
munity and used as control subjects. Non-fasting
heparinized venous blood samples were collected from
each subject with their/parental prior consent.
The total plasma proteins were measured by biuret
method, plasma albumin was measured by a colorimetric
method based on the bromocresol green dye at pH 4.2
giving a colored complex [22]. Protein Oxidation was
evaluated by measuring carbonyl group content in plasma
proteins is a marker of free radical activity. It was meas-
ured with use of Levine method [23]. 100 µl of plasma
was incubated with a 100 µl of 20 mM 2, 4-dinitrophenyl-
hydrazine (DNPH) for 60 min. Subsequently, the protein
was precipitated from the solution with the use of 20 %
trichloroaceticacid. Then it was washed three times in the
solution of ethanol and ethylacetate and dissolving in 1
ml of 6 M guanidine HCl in 60°C. The carbonyl group
content was evaluated in a spectrophotometer at wave-
length 360 nm. The results were expressed as µmol/mg of
protein. The lipid peroxidation in terms of MDA was esti-
mated by using TBARS method [24].
From all subjects, 5 – 8 ml of blood was collected in
heparinized tubes at 8.00 AM after an overnight fast and
immediately centrifuged at 1500 × g for 15 min at 4 C.
Plasma and pelleted RBC were separated stored in eppen-
dorf tubes and kept at -80 C until analysis. We measured
SOD, GPx and catalase activity in plasma according to the
methods of Beutler [25], Flohe and Gunzler [26] and
Renu et al. [27]. The vitamin A and β-carotene, ascorbic
acid,  α-tocopherol and glutathione spectrophotometri-
cally determined by Carr-Price reaction, DNP method and
TLC methods [24]. Nitric oxide estimated in plasma by
the method of Moshage et al. [28]. Electrophoresis was
carried out in 10% polyacrylamide slab gels, according to
the method of Laemmli [29].
Statistical analysis
Statistical analysis was performed by Minitab software.
Subjects with IDDM were compared with healthy con-
trols. Means and standard error of means were calculated
and differences between means were student's t-test. The
strength of association between pairs of variables was
assessed by Pearson correlation coefficient. The level of
significance was set at p < 0.05.
Results
The biochemical particulars of the study subjects includ-
ing IDDM and non-diabetic controls are given in table 1.
The subjects with diabetes had duration of the diseaseDiagnostic Pathology 2007, 2:22 http://www.diagnosticpathology.org/content/2/1/22
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ranged from 5 – 10 years. They all were being treated with
insulin. Despite of their treatment, they had hyperglyc-
emia having blood glucose levels more than 3-fold higher
than in healthy subjects. The lipid profile of IDDM is sta-
tistically insignificant changes with nondiabetics. How-
ever, the TBARS (lipid peroxidation) levels increased by 4
fold in diabetics compared to healthy controls (table 2).
No significant differences were found between patients
with type 1 diabetes and control subjects in the concentra-
tion of total, HDL, and LDL cholesterol and triglycerides
in age and in BMI.
The protein oxidation (PCG) in IDDM subjects was
increased 3.5 fold with decreasing the plasma levels of
total protein, albumin, globulin and their ratio compared
to non-diabetic subjects. In native PAGE (not shown), the
diabetic children had also decreased plasma levels of cer-
uloplasmin, ceruloglobulin and retinol binding protein
(RBP), which are the carrier proteins for copper and vita-
min A, respectively and also observed the decreased levels
of proteins – albumin, transferrin, and heptoglobulins
and variable GC globulin fractions in IDDM compared to
normal healthy controls. Table 3 shows a significant
decrease in the activities Cu-Zn super oxide dismutase,
glutathione peroxidase and catalase in children with
IDDM compared to controls. The glutathione peroxidase
in the whole blood was also decreased in diabetic chil-
dren, but their differences with those of the non-diabetic
counterparts were not statistically significant. The antioxi-
dant activity containing vitamins retinol, β-carotene, vita-
min C and vitamin E were significantly decreased in
plasma by 25 – 50 % respectively in diabetic children.
Discussion
Diabetes mellitus is a chronic, systemic, metabolic disease
defined by hyperglycemia and characterized by alterations
in the metabolism of carbohydrate, protein and lipid.
Oxidative stress thought to be increased in a system where
the rate of free radical production is increased and/or the
antioxidant mechanisms are impaired. In recent years, the
oxidative stress-induced free radicals have been impli-
cated in the pathology of IDDM [14,19,30-34].
The present study was examined the changes in both extra
and intracellular antioxidants and oxidant status in a chil-
dren suffering from IDDM. The diabetic children were
treated with insulin and yet they were hyperglycemic. Pro-
longed exposure to hyperglycemia and consequent non-
enzymatic posttranslational modification of proteins
resulting from chemical reaction between glucose and pri-
mary amino groups of proteins – glycation, and also
increased oxygen free radicals through auto oxidation of
glucose [15,33-36]. Our results are in accordance with
those of previous finding clearly show the increased glu-
cose levels induces diabetes, the overproduction of oxy-
gen free radicals and consequently increases the protein
oxidation and lipid oxidation (table 2). Plasma MDA and
PCG levels were significantly higher, which would indi-
cate that free radical mediated oxidative damage of lipids
and proteins is produced at in diabetics [35,42,42]. To our
knowledge, there are no reports in the literature concern-
ing plasma PCG levels in IDDM patients in relation with
antioxidant status. Carbonyl group formation is consid-
ered an early and stable marker for protein oxidation. Oxi-
Table 3: Effect of IDDM on the blood levels of antioxidants
Sl No. Antioxidant Control IDDM
1. Vitamin A (retinol) 2.24 ± 0.25 1.35 ± 0.32$
2. β-carotene 2.86 ± 0.34 1.83 ± 0.4$
3. Vitamin C (Ascorbic acid) 68 ± 14 38 ± 10$
4. Vitamin E (α-tocopherol) 20.4 ± 0.8 15.2 ± 1.2$
5. Glutathione peroxidase (GPx) 52 ± 5 38 ± 4$
6. Superoxide dismutase (SOD) 1620 ± 80 1240 ± 68$
7. Catalase 256 ± 32 178 ± 28$
8. Uric acid (mmol/l) 0.15 ± 0.05 0.10 ± 0.02$
Results are expressed as mean ± SD. $ p < 0.05 against the control 
values
Table 1: Biochemical characteristics of normal and IDDM 
patients
Sl. No Clinical data Normal IDDM
1. Number 20 15
2. Age 5 – 20 5 – 20
3. Body mass index (BMI) 18.14 ± 2.4 18.92 ± 3.4
4. Blood glucose 80 ± 12 342 ± 56$
5. Serum total protein 6.85 ± 0.96 5.60 ± 0.6$
6. Serum albumin 3.84 ± 0.45 2.80 ± 0.4$
7. A:G ratio 1 – 2 0.92 ± 0.12
8. Triglycerides 110 ± 34 153 ± 32
9. Cholesterol 172 ± 31 187 ± 23
10. VLDL – cholesterol 23 ± 5.6 34 ± 5$
11. LDL – cholesterol 102 ± 14 121 ± 14
12. HDL – cholesterol 38 ± 6 34 ± 8
13. Blood urea 31 ± 8 42 ± 10
14. Serum creatinine 1.10 ± 0.3 1.62 ± 0.42
15. Glycosylated Hb 6.12 ± 0.3 11.5 ± 3.2
Results are expressed as mean ± SD. $ p < 0.05 against the control 
values
Table 2: Effect of IDDM on the levels of Oxidative stress 
parameters
Sl No. Oxidative parameter Control IDDM
1. Lipid peroxidation (TBARS) 60 ± 10 231 ± 24$
2. Protein oxidation (PCG) 3.42 ± 0.5 12.2 ± 2$
3. Nitric oxide 34 ± 5.4 86 ± 6.5$
Results are expressed as mean ± SD. $ p < 0.05 against the control 
valuesDiagnostic Pathology 2007, 2:22 http://www.diagnosticpathology.org/content/2/1/22
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dized proteins constitute a substantial fraction of the
catalytically inactive or less active forms of enzymes,
which may have direct metabolic consequences [37-41].
According to Gliesner et al [35] showed no statistically sig-
nificant differences were found for any of the oxidative
stress markers (PCG) assessed between patients with DM1
and controls. In addition, weight, height, and routine
metabolic tests, including creatininemia and cholesterol
levels, were similar between the groups. The lack of signif-
icant differences between healthy controls and patients
with DM1 suggested that treatment is able to counteract
the increase in free radical production. Ahmed et al [41]
observed profound increases in proteolytic products of
glycated and oxidised proteins in diabetic patients, con-
current with much lower increases in protein glycation
and oxidation adduct residues.
Nitric oxide (NO) is an important vascular target for ROS.
Superoxide neutralizes NO, and the peroxynitrite formed
is a source of hydroxyl radicals that can cause endothelial
damage [43]. Increased levels of nitric oxide were
observed in Type I DM (table 2). Astaneie et al [44] have
shown the elevated levels of NO with total antioxidant
power. Existence of increased total antioxidant power in
the presence of normal lipid peroxidation in plasma of
type I diabetic patients indicates the existence of oxidative
stress. Oxidative stress therefore diminishes vessel
endothelium-dependent relaxation, which is apparent in
some experimental preparations even after acute exposure
to hyperglycemia. Defective endothelium-dependent
relaxation has been observed in chronic diabetic animals,
and also in type 1 and type 2 diabetic subjects [41,45,46]
and is an important potential target for antioxidant treat-
ment.
The relationship between hyperglycemia and oxygen free
radicals is supported by our results demonstrating an
association between blood levels of glucose and enzy-
matic oxidants such as super oxide dismutase and glutath-
ione peroxidase, only in children with IDDM (table 3).
The decreased erythrocyte Cu/Zn-SOD and catalase activ-
ity in our young diabetic patients also supports the
hypothesis of radical mediated injury in this disease.
These results are in agreement with others [47-49]. Circu-
lating RBC act as a sink for free radicals. Consequently,
erythrocytes are subject to a continuous flux of O2 and
H2O2. It is, therefore, possible that SOD may have an
important physiological role in combating this process,
since this enzyme can catalyze the dissimulation of two
super oxide radicals into H2O2. In the present study, on
native PAGE, the plasma concentration of ceruloplasmin
in IDDM was significantly lower than those of controls.
These results are in agreement with others [50] who
reported a significant reduction in the plasma concentra-
tion of ceuloplasmin in type I diabetic patients. It has
been reported that ceruloplasmin is immunologically
altered with decrease in enzymatic oxidants. These results
may explain the significant reduction in SOD activity in
IDDM patients, since increased H2O2 and decreased ceru-
loplasmin [51]. Selenium-dependent glutathione peroxi-
dase (GPx), which works in parallel with SOD, protects
cell proteins and cell membranes against oxidative dam-
age. In the present sudy, the GPx activity was decreased
significantly compared to that of the controls and a nega-
tive correlation coefficient between GPx activity and
blood glucose concentration was observed in these chil-
dren (table 3). However, in the published lieterature, the
GPx response to diabetes has been conflicting. Diabetics
have been reported to be associated with increased
[48,52] decreased [53] or unchanged [54]. In lieu with
GPx, the catalase activities were also decreased in diabetes
compared to control subjects (table 3). The low GPx activ-
ity could be directly explained by either low GSH content
or enzyme inactivation under sever oxidative stress.
In addition to antioxidant enzyme activities, the capacity
of the antioxidant system to cope with or trap the free rad-
icals generated under normal or pathological conditions
was evaluated by measuring the level of total antioxidant
status. It reflects the status of α-tocopherol, vitamin A, β-
carotene, ascorbic acid, albumin, uric acid and other anti-
oxidants [42,49,57]. These extracellular nonenzymatic
antioxidants delay or inhibit the oxidative process.
Enhanced lipid peroxidation increases the need for lipid
soluble antioxidants, such as α-tocopherol and vitamin A
and  β-carotene. A significance difference in the mean
plasma concentration of total antioxidant status was
observed in IDDM patients (table 3). Low levels of vita-
min E are associated with increased incidence of diabetes
and some research suggests that people with diabetes have
decreased levels of antioxidants [32,42,55]. People with
diabetes may also have greater antioxidant requirements
because of increased production of free radicals in hyper-
glycemia [56]. The results of Martin-Gallan et al [42]
clearly show systemic peroxidative damage associated
with insufficient defense mechanisms against ROS to be
already present at clinical onset of type 1 diabetes mellitus
in children and adolescents. The present study has also
demonstrated a significantly lower plasma ascorbate chil-
dren compared with their controls. A significant negative
correlation coefficient between blood glucose and vita-
min C has been observed. Patients with diabetes or the
metabolic syndrome have low levels of the antioxidant
vitamin C [58,59] and also control the diabetes [33].
Chen et al [59] shown that high-dose oral vitamin C par-
tially replenishes vitamin C levels in patients with Type 2
diabetes and low vitamin C levels but does not improve
endothelial dysfunction or insulin resistance.Diagnostic Pathology 2007, 2:22 http://www.diagnosticpathology.org/content/2/1/22
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The findings of the present study suggest that diabetes in
an altered metabolic state of oxidation-reduction and that
it is convenient to give therapeutic interventions with
antioxidants. The loss of antioxidant capacity is statisti-
cally associated with accelerated aging processes in dia-
betic patients, due to an increase in basal oxidation
products of etrythrocytes associated with monosaccharide
autooxidative glycation [4,11,18,60]. Our present work
takes into account the hypothesis involving the relation
between individual components in the intact clinical
model and the complex oxidant-antioxidant plasmatic
systemic balance. We clearly identified antioxidant mark-
ers that were affected in the presence of IDDM; include
SOD, plasma albumin, ascorbic acid and α-tocopherol.
Theoretically, one should be able to reverse these effects
through dietary supplementation, especially of vitamin C
and E.
Abbreviations used
IDDM – Insulin dependent diabetes mellitus, PAGE –
Polyacrylamide gel electrophoresis, MDA – Melondialde-
hyde, PCG – Protein carbonyl groups, TBARS – Thiobar-
butyricacid reactives species, TLC – Thin layer
chromatography, GPx – Glutathione peroxidase, NO –
Nitric oxide, SOD – Superoxide dismutase.
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